Edward Bell

Edward Bell's work experience includes significant roles in various pharmaceutical companies. Edward is currently the Vice President of Operations at Huvepharma, Inc. Prior to this, they held executive positions at Merck, including Executive Director of Vaccine Process Development and Commercialization and Director of Project Management for Global Vaccine Network Strategy and Execution. Edward also worked at Pfizer as a Manager in Viral Operations and Aseptic Support, Manager of the Human Bio Monoclonal Antibody Pilot Plant, and Project Manager and Process Developer. Throughout their career, Edward has demonstrated expertise in vaccine production, process development, and strategic planning.

Edward Bell earned a Master of Science degree in Molecular Genetics from the University of Nebraska-Lincoln from 1989 to 1991. Prior to that, they obtained a Bachelor of Science degree in Biology from Nebraska Wesleyan University, attending from 1985 to 1989. Additionally, Edward acquired a Certified Lean Six Sigma Sensei (CLSSS) qualification from Villanova University, although the specific dates for this certification are not provided.